Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
This product must not be administered to humans or animals
Identification of the binding domain for NADP+ of human glucose-6-phosphate dehydrogenase by sequence analysis of mutants
No peer-reviewed human RCT has yet validated a subcutaneous dose in people as of 2026 [5][6]
Post-chemotherapy-persister cells resistant to lapatinib treatment in breast, melanoma, lung, and ovarian cancer have been characterized as GPx4-dependent (63)
Manufactured to research-grade specifications, KCL-GHK is intended exclusively for scientific investigation and laboratory use
US$ 21.94
US$ 25.07
US$ 23.90
US$ 27.66
US$ 26.22
US$ 21.88
US$ 22.27
US$ 22.21
